Ecto
Atlanta
About Ecto
Ecto develops technology at the intersection of data and biology to enable a more efficient and sustainable aquaculture industry. They collaborate with farmers to streamline production and health management by leveraging advanced molecular tools and digital technologies. To date, Ecto's solutions have enabled farmers to create 51,510,714 additional healthy servings of protein. Ecto has offices in Boston, Atlanta, and Stavanger Norway, and serves customers all over the world. The company was founded at Harvard Innovation Labs in 2013 by Dmitry Kozachenok and James Webb. The company has received competitive research grants from the US National Science Foundation, US Department of Agriculture, and Innovation Norway.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.6M
- Last round: Series Unknown (Oct 2023)
- Website: ecto.com
- Phone: 6179996166
Industries & Categories
Aquaculture, Biotechnology, Health Diagnostics, Information Technology
Social Profiles
Canonical: https://fsome.com/organization/ecto-108519 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.